1 Week Left: Join WFH Global Summit on Advancing Access for Bleeding Disorders Community
The World Federation of Hemophilia (WFH) shared an inviting post on X:
”Just 1 week left until the 2025 WFH Global Policy and Access Summit (GPAS)! Join us for powerful sessions on improving access to diagnosis, treatment, and care for people with bleeding disorders around the world.”
To register for free, follow the link.
WFH is encouraging everyone to not miss the Global Policy and Access Summit (GPAS), happening in just a week.
The upcoming two-day virtual summit will bring together voices from across the bleeding disorders community to focus on one shared goal: expanding access to diagnosis, treatment, and care worldwide.
Presentations and panel discussions will explore strategies to address persistent barriers and highlight successful models from different regions, featuring local and international experts, representatives from national governments, healthcare professionals, WFH National Member Organization (NMO) leaders, and patient advocates working on the front lines.
This summit? It’s more than a meeting—it’s a coordinated step toward equity in care for all people living with bleeding disorders.
To keep up with the news on global conferences and summits, stay informed with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia
